Your browser doesn't support javascript.
loading
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation.
Cheng, Michael L; Huang, Yeying; Luong, Nhi; LoPiccolo, Jaclyn; Nishino, Mizuki; Sholl, Lynette M; Chirieac, Lucian R; Santucci, Alison D; Rabin, Michael S; Jänne, Pasi A; Coker, Shodeinde; Diamond, Jennifer R; Hilton, John; Shapiro, Geoffrey I; French, Christopher A.
Afiliação
  • Cheng ML; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Huang Y; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Luong N; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • LoPiccolo J; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Nishino M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Sholl LM; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Chirieac LR; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Santucci AD; Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Rabin MS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Jänne PA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Coker S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Diamond JR; Boston Medical Center, Boston, MA.
  • Hilton J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Shapiro GI; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • French CA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
JCO Precis Oncol ; 7: e2200633, 2023 06.
Article em En | MEDLINE | ID: mdl-37384867

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article